Nature’s Sunshine Products, Inc. reported a notable increase in financial performance for the third quarter of 2025, with consolidated net sales reaching $128.3 million, a 12.0% increase from $114.6 million in the same period of 2024. For the nine months ended September 30, 2025, net sales totaled $356.3 million, up 6.0% from $336.2 million year-over-year. The company attributed this growth to strong sales across its Asia, Europe, and North America segments, despite a decline in Latin America. Gross profit for the third quarter was $94.0 million, representing a gross margin of 73.3%, compared to 71.3% in the prior year, driven by cost-saving initiatives and favorable foreign exchange rates.
The company’s operating income for the third quarter increased significantly to $9.0 million, up 69.9% from $5.3 million in the same quarter of 2024. This improvement was supported by a reduction in cost of sales as a percentage of net sales, which fell to 26.7% from 28.7%. Selling, general, and administrative expenses also rose, totaling $45.7 million for the quarter, primarily due to increased digital marketing investments and consultant events. Net income attributable to common shareholders was $5.3 million, or $0.30 per share, compared to $4.3 million, or $0.23 per share, in the previous year.
In terms of operational developments, Nature’s Sunshine has been actively expanding its market presence. The company reported a 17.1% increase in net sales in Asia, with significant contributions from markets such as Japan and China. The company also announced the acquisition of interests in its joint ventures in Hong Kong and Shanghai from Fosun Industrial for a total of $7 million, which will enhance its operational control in these key markets. The company’s total assets increased to $264.8 million as of September 30, 2025, up from $240.9 million at the end of 2024, reflecting growth in cash and inventory levels.
Nature’s Sunshine's customer engagement metrics showed positive trends, with an increase in active consultants contributing to higher sales volumes. The company reported a total of 17,560 shares outstanding as of September 30, 2025, down from 18,483 shares at the end of 2024, reflecting ongoing share repurchase activities. The company’s cash position improved to $95.6 million, bolstered by strong operating cash flows of $25.4 million for the nine months ended September 30, 2025, compared to $13.1 million in the prior year.
Looking ahead, Nature’s Sunshine remains optimistic about its growth trajectory, particularly in international markets. The company anticipates continued revenue growth driven by its strategic initiatives, including product innovation and enhanced marketing efforts. However, it also acknowledges potential risks related to geopolitical tensions, currency fluctuations, and regulatory challenges that could impact its operations. The company plans to maintain its focus on expanding its product offerings and improving consultant engagement to drive future sales growth.
About NATURES SUNSHINE PRODUCTS INC
Nature’s Sunshine Products, Inc. is a global health and wellness company specializing in the manufacturing and direct selling of over 800 nutritional, immune, cardiovascular, digestive, personal care, and weight management products. Operating through a network of independent consultants across multiple regions, it emphasizes quality ingredients, regulatory compliance, and sustainable sourcing to deliver health solutions and business opportunities worldwide.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.